Target intelligence / Profile preview

Immune System Desensitization via Gradual Exposure

Molecular classification
Immunotherapy, Biological Therapy
01

Overview

Desensitization of the immune system through gradual exposure is a therapeutic approach designed to reduce hypersensitivity reactions by systematically exposing the immune system to increasing amounts of a specific allergen. This process aims to retrain the immune response, leading to long-term tolerance and reduced symptoms upon future exposures. The therapy involves controlled administration of small but gradually increasing doses of an allergen, either via subcutaneous injections, oral ingestion, or other routes. Over time, there is a shift in antibody production from IgE toward IgG4 antibodies, and regulatory T cells are induced, further promoting tolerance.

Other names
Allergen ImmunotherapyDesensitisationAllergy ShotsOral Immunotherapy (OIT)Subcutaneous Immunotherapy (SCIT)Rapid Desensitization
02

Mechanism of action

Gradual exposure to increasing doses of allergen leads to: - Suppression of mast cell and basophil reactivity. - Shift from IgE to IgG4 antibody production. - Induction of regulatory T cells (Tregs). - Promotion of immune tolerance.

03

Biological functions

Immune tolerance inductionHypersensitivity reductionModulation of IgE responseRegulatory T cell inductionMast cell/basophil desensitization
04

Disease associations

Allergic rhinitisFood allergiesInsect venom allergiesDrug allergies
05

Safety considerations

AnaphylaxisLocal injection site reactionsExacerbation of allergic symptomsNeed for epinephrine auto-injectorRisk of developing new allergies
06

Interacting drugs

Allergens (administered in controlled doses)

3 more in the full profile.

07

Biomarkers

Allergen-specific IgE levelsAllergen-specific IgG4 levelsMast cell/basophil activation markersRegulatory T cell populations (e.g., FoxP3+ Tregs)Cytokine profiles (e.g., IL-10, TGF-beta)

Beyond the preview

Go deeper on Immune System Desensitization via Gradual Exposure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune System Desensitization via Gradual Exposure.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call